JP2007105048A - Process for producing d-n-carbamoyl-alpha-amino acids - Google Patents

Abstract

<P>PROBLEM TO BE SOLVED: To provide a highly efficient process for producing D-N-carbamoyl-α-amino acids. <P>SOLUTION: Disclosed are a DNA fragment containing a gene for a hydantoinase derived from a specific microorganism of the genus Bacillus, Agrobacterium or Pseudomonas, a vector DNA and a transformed microorganism. Also disclosed is a process for producing D-N-carbamoyl-α-amino acids from 5-substituted hydantoins using a hydantoinase produced from a transformed microorganism transformed with the recombinant DNAs. <P>COPYRIGHT: (C)2007,JPO&INPIT

Description

  The present invention relates to a method for producing DN-carbamoyl-α-amino acid, in particular, an enzyme (hereinafter referred to as an enzyme that converts 5-substituted hydantoin into a corresponding DN-carbamoyl-α-amino acid by asymmetric cleavage hydrolysis) The present invention relates to a method for producing DN-carbamoyl-α-amino acid using a novel transformant having a gene involved in hydantoinase.

  The optically active DN-carbamoyl-α-amino acid can be converted into the corresponding optically active D-α-amino acid, and the optically active D-α-amino acid is an important compound as a pharmaceutical intermediate. In particular, D-phenylglycine, D-parahydroxyphenylglycine and the like as production intermediates of semisynthetic penicillins and semisynthetic cephalosporins are industrially useful compounds.

  As a method for producing DN-carbamoyl-α-amino acid, 5-substituted hydantoin is asymmetrically cleaved and hydrolyzed to the corresponding DN-carbamoyl-α-amino acid using the enzymatic action of microorganisms. A conversion method is known and described in Patent Documents 1-4.

  In addition, a hydantoinase activity is obtained by obtaining a gene involved in hydantoinase, which is an enzyme that converts 5-substituted hydantoin into the corresponding DN-carbamoyl-α-amino acid from a thermophilic bacterium, and introducing the gene into a mesophilic bacterium. Patent Document 5 describes a method for producing a recombinant microorganism having the above. In Patent Document 6, a hydantoinase gene fragment is isolated from bacteria belonging to Agrobacterium and introduced into Escherichia coli or Agrobacterium bacteria to express the activity.

    The above-described methods utilizing the enzymatic action of microorganisms have drawbacks such as that the microorganisms known as enzyme supply sources are not sufficient in the amount of enzyme production, and the culture medium is expensive.

  In addition, the recombinant microorganism shown in Patent Document 5 has an enzyme activity that is only several times higher than that of a spore-forming thermophile having hydantoinase activity, and the amount of enzyme produced is not sufficient. .

  In addition, no examples have been shown in which the above-mentioned recombinant microorganism is used to asymmetrically cleave and hydrolyze 5-substituted hydantoin to produce and accumulate the corresponding DN-carbamoyl-α-amino acid.

JP-A-53-91189 Japanese Patent Laid-Open No. 53-44690 JP-A-53-69884 JP-A-53-133688 JP-A-62-87089 International Publication No. 94/00577 Pamphlet

  In order to solve such problems, the present invention creates microorganisms with extremely high enzyme productivity and uses the enzyme source thus obtained to convert DN-carbamoyl-α-amino acid. The purpose is to produce efficiently.

  Methods for obtaining a microorganism that produces hydantoinase using recombinant DNA techniques are described in Patent Documents 5 and 6, but the microorganism that is the source of the hydantoinase gene obtained the hydantoinase gene in the present invention. It is completely different from microorganisms. Furthermore, the base sequence and amino acid sequence of the hydantoinase gene are quite different from those of the present invention.

(式中、Ｒはフェニル基、水酸基で置換されたフェニル基、アルキル基、置換アルキル基、アラルキル基またはチエニル基を示す。)で表わされる化合物である５記載の製造法。
７．バチルス ｓｐ．ＫＮＫ２４５（ＦＥＲＭ ＢＰ−４８６３）由来のヒダントイナーゼをコードする遺伝子を含むＤＮＡ断片と、プラスミド（pＵＣＮＴ）との組換えにより得られ、図２〜４のいずれかに示す制限酵素切断地図を有する組換えプラスミド。
８．組換えプラスミドが、pＴＨ１０２、pＴＨ１０３またはpＴＨ１０４である７記載の組換プラスミド。
９．アグロバクテリウム ｓｐ．ＫＮＫ７１２（ＦＥＲＭ ＢＰ−１９００）由来のヒダントイナーゼをコードする遺伝子を含むＤＮＡ断面とプラスミドpＵＣ１８との組換えによって得られ、図１の制限酵素地図を有する組換えプラスミド。
１０．組換えプラスミドがpＡＨ１０４３である９記載の組換えプラスミド。
１１．シュードモナス ｓｐ．ＫＮＫ００３Ａ（ＦＥＲＭ ＢＰ−３１８１）由来のヒダントイナーゼをコードする遺伝子を含むＤＮＡ断片と、プラスミドpＵＣ１８の組換えによって得られ、図５の制限酵素地図を有する組換えプラスミド。
１２．組換えプラスミドがpＰＨＤ３０１である１１記載の組換えプラスミド。
１３．配列表配列番号１のアミノ酸配列のアミノ酸番号１〜４５７のアミノ酸配列の全部または一部をコードする５−置換ヒダントインを不斉的に開裂加水分解して、対応するＤ−Ｎ−カルバモイル−α−アミノ酸に変換する酵素活性を示す蛋白質の遺伝子。
１４．配列表配列番号１のアミノ酸配列のアミノ酸番号１〜４５７のアミノ酸配列の全部または一部を含み、５−置換ヒダントインを不斉的に加水分解して対応するＤ−Ｎ−カルバモイル−α−アミノ酸に変換する活性を有する酵素蛋白質。
１５．配列表配列番号３のアミノ酸配列のアミノ酸番号１〜４８５のアミノ酸配列の全部または一部をコードする５−置換ヒダントインを不斉的に開裂加水分解して、対応するＤ−Ｎ−カルバモイル−α−アミノ酸に変換する酵素活性を示す蛋白質の遺伝子。
１６．配列表配列番号１の塩基番号１〜２５１８の塩基配列の全部または一部もしくはこれと等価の塩基配列を持ち、５−置換ヒダントインを不斉的に開裂加水分解して、対応するＤ−Ｎ−カルバモイル−α−アミノ酸に変換する酵素活性を示す蛋白質の遺伝子を含むＤＮＡ断片。
１７．配列表配列番号３の塩基番号１〜１５６９の塩基配列の全部または一部もしくはこれと等価の塩基配列を持ち、５−置換ヒダントインを不斉的に開裂加水分解して、対応するＤ−Ｎ−カルバモイル−α−アミノ酸に変換する酵素活性を示す蛋白質の遺伝子を含むＤＮＡ断片。
１８．配列表配列番号３のアミノ酸配列のアミノ酸番号１〜４８５のアミノ酸配列の全部または一部を含み、５−置換ヒダントインを不斉的に加水分解して対応するＤ−Ｎ−カルバモイル−α−アミノ酸に変換する活性を有する酵素蛋白質。 The present invention provides the following:
1. Bacillus sp. KNK245 (FERM BP-4863), Agrobacterium sp. KNK712 (FERM BP-1900) or Pseudomonas sp. Using a recombinant DNA of a DNA fragment containing a gene involved in hydantoinase derived from KNK003A (FERM BP-3181) and a vector DNA, Escherichia, Pseudomonas, Flavobacterium, Bacillus, Serratia, Agrobacterium D which causes the enzyme produced by a transformant obtained by transforming a host cell such as a microorganism belonging to the genus Baum, Corynebacterium, or Brevibacterium to act on a 5-substituted hydantoin in an aqueous medium A method for producing N-carbamoyl-α-amino acid.
2. 2. The transformed microorganism according to 1, wherein the host microorganism is selected from microorganisms belonging to the genus Escherichia, Pseudomonas, Flavobacterium, Bacillus, Serratia, Agrobacterium, Corynebacterium or Brevibacterium.
3. The transformed microorganisms are Escherichia coli HB101 pTH102, Escherichia coli HB101 pTH103, Escherichia coli HB101 pTH104 (FERM BP-4864), Escherichia coli (3 EscherichiAH 104B). 3. The transformed microorganism according to 2, which is FERM BP-4865) or Escherichia coli HB101 pPHD301 (FERM BP-4866).
4. A 5-substituted hydantoin is asymmetrically hydrolyzed and converted to the corresponding DN-carbamoyl-α-amino acid, using the transformed microorganism according to any one of 4.1 to 3 Enzyme production method.
A method for producing DN-carbamoyl-α-amino acid from 5-substituted hydantoin, which comprises using the enzyme obtained by the production method according to 5.4.
6.5-Substituted hydantoins have the general formula (1):

6. The production method according to 5, wherein R is a phenyl group, a phenyl group substituted with a hydroxyl group, an alkyl group, a substituted alkyl group, an aralkyl group or a thienyl group.
7). Bacillus sp. A recombinant plasmid obtained by recombination of a DNA fragment containing a gene encoding hydantoinase derived from KNK245 (FERM BP-4863) with a plasmid (pUCNT) and having a restriction enzyme cleavage map shown in any of FIGS. .
8). 8. The recombinant plasmid according to 7, wherein the recombinant plasmid is pTH102, pTH103 or pTH104.
9. Agrobacterium sp. A recombinant plasmid obtained by recombination of a DNA cross section containing a gene encoding a hydantoinase derived from KNK712 (FERM BP-1900) with the plasmid pUC18 and having the restriction enzyme map of FIG.
10. 10. The recombinant plasmid according to 9, wherein the recombinant plasmid is pAH1043.
11. Pseudomonas sp. A recombinant plasmid obtained by recombination of a DNA fragment containing a gene encoding hydantoinase derived from KNK003A (FERM BP-3181) and the plasmid pUC18 and having the restriction enzyme map of FIG.
12 12. The recombinant plasmid according to 11, wherein the recombinant plasmid is pPHD301.
13. A 5-substituted hydantoin that encodes all or part of the amino acid sequence of amino acid numbers 1 to 457 of the amino acid sequence of SEQ ID NO: 1 is asymmetrically cleaved and hydrolyzed, and the corresponding DN-carbamoyl-α- A protein gene that shows enzymatic activity to convert to amino acids.
14 It contains all or part of the amino acid sequence of amino acid numbers 1 to 457 of the amino acid sequence of SEQ ID NO: 1, and asymmetrically hydrolyzes 5-substituted hydantoin to the corresponding DN-carbamoyl-α-amino acid. An enzyme protein having an activity to convert.
15. A 5-substituted hydantoin that encodes all or part of the amino acid sequence of amino acid numbers 1 to 485 of the amino acid sequence of SEQ ID NO: 3 is asymmetrically cleaved and hydrolyzed, and the corresponding DN-carbamoyl-α- A protein gene that shows enzymatic activity to convert to amino acids.
16. It has the whole or a part of the base sequence of base numbers 1 to 2518 in the sequence listing SEQ ID NO: 1 or a base sequence equivalent thereto, and asymmetrically cleaves and hydrolyzes 5-substituted hydantoins to give the corresponding DN- A DNA fragment comprising a gene of a protein exhibiting enzymatic activity for conversion to carbamoyl-α-amino acid.
17. It has the whole or a part of the base sequence of base numbers 1 to 1569 of the sequence listing SEQ ID NO: 3 or a base sequence equivalent thereto, and asymmetrically cleaves and hydrolyzes the 5-substituted hydantoin to give the corresponding DN- A DNA fragment comprising a gene of a protein exhibiting enzymatic activity for conversion to carbamoyl-α-amino acid.
18. Including all or part of the amino acid sequence of amino acid numbers 1 to 485 of the amino acid sequence of SEQ ID NO: 3 and asymmetrically hydrolyzing the 5-substituted hydantoin to the corresponding DN-carbamoyl-α-amino acid An enzyme protein having an activity to convert.

  A transformant with extremely high productivity of hydantoinase as obtained by the present invention has not been known so far, and DN-carbamoyl- is very efficiently and economically produced by allowing the enzyme of this transformant to act. It has become possible to produce α-amino acids.

    The DNA fragment containing the gene used in the present invention is Bacillus sp. KNK245 Agrobacterium sp. KNK712 or Pseudomonas sp. It can be obtained from KNK003A. Agrobacterium sp. KNK712 and Pseudomonas sp. KNK003A has already been deposited by the applicant under the accession numbers of FERM BP-1900 and FERM BP-3181, respectively, at the Institute of Biotechnology, Ministry of International Trade and Industry, and details thereof are described in WO92 / 10579. Is a known strain. Bacillus sp. KNK245 is a strain newly found by the present inventors and has been deposited with the Institute under the accession number of FERM BP-4863 since November 12, 1994.

かかる菌株からヒダントイナーゼ遺伝子を得るには、通常以下の様に行う。 Next, Bacillus sp. The bacteriological properties of KNK245 are shown.

In order to obtain a hydantoinase gene from such a strain, it is usually carried out as follows.

  First, chromosomal DNA is extracted from the cells of the microorganism, then chromosomal DNA is partially hydrolyzed with an appropriate restriction enzyme such as Sau3AI, and then combined with vector DNA to have various chromosomal DNA fragments. Recombinant DNA is obtained as a gene library (see JP-A-58-126789 and US Pat. No. 4,237,224).

  Then, a recombinant bacterium containing the target gene is selected from this gene library, which detects the expressed protein using the enzyme activity or the like as an index, or analyzes the N-terminal sequence of the protein and corresponding DNA. It can be performed by synthesizing a probe and detecting the presence of a gene by colony hybridization or the like. Alternatively, a gene can be obtained by colony hybridization or polymerase chain reaction (PCR) using a DNA primer obtained by synthesizing an appropriate sequence based on the known hydantoinase base sequence. If a gene can be obtained, its base sequence is analyzed. In addition, by culturing a microorganism that produces hydantoinase and a recombinant microorganism into which this enzyme gene has been introduced, the produced enzyme is purified, the molecular weight of the protein is determined, and the amino acid sequence near the amino terminus is converted to a gas phase protein sequencer. Etc.

  Next, the DNA base sequence is compared with the amino terminal sequence of the protein to determine the translation start site of the base sequence portion encoding the hydantoinase protein into the protein, and the enzyme protein in the gene portion from this site to the translation stop codon. Confirm that the gene is encoded in consideration of the relationship with the molecular weight of the protein, and confirm that it is the gene of interest (Molecular Cloning, A Laboratory Manual, 2nd Ed., Cold Spring Harbor Laboratory Press, Chapter 4, Chapter Chapter 13). As a result, Agrobacterium sp. KNK712 and Pseudomonas sp. DNA fragments of SEQ ID NOs: 1 and 3 in the sequence listing were obtained from KNK003A. Bacillus sp. A DNA fragment containing a gene encoding hydantoinase was also obtained from KNK245. As is well known, since a gene encoding the enzyme and / or a DNA fragment containing the enzyme thus obtained usually has a plurality of base codons corresponding to one amino acid, the gene and / or It is equivalent to a DNA fragment having another base sequence encoding an amino acid sequence corresponding to the DNA fragment.

  The vectors used in the present invention include Escherichia, Pseudomonas, Flavobacterium, Bacillus, Serratia, Corynebacterium, or Brevibacterium genus-derived plasmids and phages that can autonomously replicate in cells of the genus Alternatively, derivatives thereof can be used.

  For example, “Recombinant DNA Experiment Guidelines -Commentary / Q & A-” (edited by the Recombinant DNA Experiment Guidelines Study Group, supervised by the Science and Technology Agency, Life Sciences Section, Daiichi Law Publishing Co., Ltd., revised on September 24, 1991) 25 The host-vector system described on pages -27 and 36-38 can be used. Moreover, by using a vector modified to have a strong structural promoter and using a recombinant DNA in which a translation initiation site is linked to an appropriate position on the vector, the amount of enzyme produced can be increased. . Both ends of these fragments are cleaved with a restriction enzyme to prepare a recombinant DNA with an appropriate vector, and Escherichia, Pseudomonas, Flavobacterium, Bacillus, Serratia, Agrobacterium, Coryne A recombinant microorganism that produces hydantoinase by directly transforming a microorganism belonging to the genus Bacteria or Brevibacterium can be obtained.

  Without directly transforming the above species, for example, the target gene is once cloned in a host vector system of another microorganism such as Escherichia coli, and then a recombinant DNA with an appropriate vector is prepared. Then, even if a bacterial species of the above genus is transformed, a recombinant microorganism that similarly produces hydantoinase can be obtained.

  For recombinant production, S. N. Cohen et al. US Pat. No. 4,237,224, Gene manipulation experiment method [Yasutaka Takagi, Kodansha Scientific (1980), Method in Enzymology, 68, Recombinant DNA [Ray Mv, Academic Press (1979)], Special Descriptions of documents such as the specification of Kokai 58-126789 can be widely applied.

  Using a recombinant DNA in which a translation initiation site is linked to an appropriate position on the vector using a vector modified by removing unnecessary DNA from the cloned target gene and having a strong promoter, the above host The amount of target enzyme produced can be increased by transforming the fungus and using the resulting transformant.

  The transformed strain can be expressed in the introduced recombinant DNA by culturing in a normal nutrient medium. When the recombinant DNA is given a property derived from gene DNA or vector DNA, the medium may be supplemented with a drug according to the property.

  In order to obtain the transformant thus obtained as an enzyme source, culture can be carried out using a normal medium. If necessary, hydantoin compounds, uracil, isopropyl-1-thio-β-D -Treatment for enzyme induction, such as addition of galactoside (IPTG), temperature rise, etc., can also be performed. The medium used for culturing the transformed strain may be a common medium usually containing a carbon source, a nitrogen source and inorganic ions. When organic micronutrients such as vitamins and amino acids are added thereto, favorable results are often obtained. As the carbon source, carbohydrates such as glucose and sucrose, organic acids such as acetic acid, alcohols and the like are appropriately used. As the nitrogen source, ammonia gas, aqueous ammonia, ammonium salt and the like are used. As inorganic ions, phosphate ions, magnesium ions, potassium ions, iron ions, manganese ions, cobalt ions, nickel ions, copper ions, aluminum ions, molybdenum ions, and the like may be used.

  Desirable results can be obtained by culturing for 1 to 10 days while controlling the culture at an appropriate range of pH 4 to 8 and temperature 25 to 60 ° C.

  Examples of the mode in which the enzyme produced by the transformed strain acts include a culture solution of the transformed strain, bacterial cells, treated bacterial cells, enzymes extracted from the bacterial cells, and immobilized bacterial cells.

  As the microbial cells, any of the cultures after completion of the culture can be used, such as bacteria isolated from the culture solution and washed cells. The treated cells include freeze-dried cells, acetone-dried cells, cells that have been contacted with toluene or a surfactant, cells that have been treated with lysozyme, cells that have been sonicated, and cells that have been mechanically ground. In addition, an enzyme extract having a hydantoinase activity obtained from a treated product of these cells, an immobilized product of these cells, an insolubilized product of the treated cells, a carrier for immobilizing enzyme proteins (for example, , Anion exchange resin) and the like can be used. For the immobilization method, for example, JP-A-63-185382 is referred to.

  Supports used for immobilization include phenol formaldehyde anion exchange resins such as Duolite A568 or DS17186 (Rohm and Haas: registered trademark), Amberlite IRA935, IRA945, IRA901 ( Various amines such as polystyrene resins such as Rohm and Haas (registered trademark), Lewatit OC1037 (Bayer: registered trademark), Diaion EX-05 (Mitsubishi Chemical Industry: registered trademark) Various anion exchange resins having an ammonium salt or diethanolamine type functional group are suitable. Other supports such as DEAE-cellulose can also be used.

  Furthermore, in order to make the adsorption of the enzyme stronger and more stable, a cross-linking agent is usually used, but a preferable example is glutaraldehyde. As the enzyme to be used, not only a purified enzyme but also various purified enzymes such as a partially purified enzyme, a cell disruption solution, and a cell-free extract can be used. For the preparation of the immobilized enzyme, a usual preparation method such as crosslinking treatment after adsorbing the enzyme to the support can be used.

で表わされる化合物が挙げられる。 The 5-substituted hydantoin used as a substrate for the enzyme reaction in the present invention is not particularly limited, and any of those usually used for this kind of reaction may be used. For example, the general formula (1):

The compound represented by these is mentioned.

  The substituent R in the compound of the general formula (1) can vary widely, but in particular, in order to give industrially useful compounds such as pharmaceutical intermediates, R is a phenyl group or a phenyl group substituted with a hydroxyl group. , An alkyl group, a substituted alkyl group, an aralkyl group, or a thienyl group. In the case of a phenyl group substituted with a hydroxyl group, the hydroxyl group is one or more and may be substituted at any position of o-, m-, and p-, but a p-hydroxyphenyl group is typical. is there. The alkyl group has 1 to 4 carbon atoms, and the corresponding DN-carbamoyl-α-amino acid is DN-carbamoyl-alanine, DN-carbamoyl-valine, DN-carbamoyl-leucine, D- It is a group that becomes N-carbamoyl-isoleucine or the like. A substituted alkyl group is a group in which an alkyl group having 1 to 4 carbon atoms is substituted with a hydroxyl group, an alkylthio group, a carboxyl group, an amino group, a phenyl group, a phenyl group substituted with a hydroxyl group, an amide group, etc. -N-carbamoyl-amino acid is DN-carbamoyl-serine, DN-carbamoyl-threonine, DN-carbamoyl-methionine, DN-carbamoyl-cysteine, DN-carbamoyl-asparagine, DN -Carbamoyl-glutamine, DN-carbamoyl-tyrosine, DN-carbamoyl-tryptophan, DN-carbamoyl-aspartic acid, DN-carbamoyl-glutamic acid, DN-carbamoyl-histidine, DN- Carbamoyl-lysine, DN-carbamoyl-arginine, DN-ca Bamoiru - citrulline, or the like to become group. The aralkyl group is, for example, benzyl or phenethyl group having 7 to 8 carbon atoms, and the corresponding DN-carbamoyl-α-amino acid is DN-carbamoyl-phenylalanine or the like.

  As the aqueous medium, one containing water, a buffer solution, or an organic solvent such as ethanol is used. Furthermore, nutrients necessary for the growth of microorganisms, antioxidants, surfactants, coenzymes, hydroxylamines, metals, and the like can be added to the aqueous medium as necessary.

  When the cells of the microorganism are cultured in an aqueous medium and the cells are brought into contact with the 5-substituted hydantoin, the carbon source containing the 5-substituted hydantoin and necessary for the growth of the microorganism, nitrogen Sources and aqueous media containing nutrients such as inorganic ions are used. Furthermore, when organic / micronutrients such as vitamins and amino acids are added, favorable results are often obtained. As the carbon source, carbohydrates such as glucose and sucrose, organic acids such as acetic acid, alcohols and the like are appropriately used. As the nitrogen source, ammonia gas, aqueous ammonia, ammonium salt and the like are used. As inorganic ions, phosphate ions, magnesium ions, potassium ions, iron ions, manganese ions, cobalt ions, nickel ions, copper ions, aluminum ions, molybdenum ions, and the like may be used.

  Cultivation is performed under aerobic conditions while controlling the pH within a suitable range of 4 to 8 and a temperature of 25 to 60 ° C. If the culture is performed for about 1 to 10 days, the 5-substituted hydantoin is efficiently exchanged only for DN-carbamoyl-α-amino acid.

  On the other hand, the culture broth of the microorganism is used as it is, in which the cultured cells, treated cells, enzyme extract, immobilized cells, insolubilized cells or immobilized enzyme protein, and 5-substituted hydantoin are dissolved or suspended. When the reaction is carried out in a turbid aqueous medium, the temperature may be adjusted to an appropriate temperature of 10 to 80 ° C. and kept for a while or stirred while maintaining the pH at 4 to 9.5. Thus, after about 5 to 100 hours, the substrate by hydantoinase undergoes a D-specific hydrolysis reaction and chemical racemization of the substrate at the same time, and the D-type, DL-type, or L-type 5-substitution All hydantoins are converted to the corresponding DN-carbamoyl-α-amino acids and accumulate in large amounts in aqueous media. The 5-substituted hydantoin may be added in portions as the reaction proceeds.

  The produced DN-carbamoyl-α-amino acid can be separated and purified by a conventional separation method.

Using the DN-carbamoyl-α-amino acid separated or purified obtained by the method described above, or the reaction solution obtained by the hydantoinase reaction, DN-carbamoyl-α-amino acid chemically or D-α-amino acids can be easily obtained by conversion by the action of an enzyme having decarbamoyl activity.
Hereinafter, the present invention will be described specifically by way of examples.

Separation of Hydantoinase-Activating Bacteria from Soil 0.5 g of a soil sample was suspended in 2 ml of physiological saline and allowed to stand. %, Yeast extract 1.0%, sodium chloride 0.3%, agar 2.0%; pH 7.5). This was cultured at 50 ° C. for 2 days, and the obtained colonies were transplanted to a plate medium in which 0.1% uracil and 20 ppm of manganese chloride were added to the same plate medium for separation, and further cultured at 50 ° C. for 1 day. The bacterial cells thus obtained were suspended in 100 μl of a reaction substrate solution (DL- (parahydroxyphenyl) hydantoin 30 mM, sodium sulfite 0.1%, carbonate buffer 50 mM) and reacted at 50 ° C. for 2 hours. Next, the reaction solution is spotted on a TLC plate, developed with a developing solvent of butanol: acetic acid: water (4: 1: 1), and a yellow spot is detected using a concentrated hydrochloric acid solution of 10% p-dimethylaminobenzaldehyde. Thus, a strain producing N-carbamoylparahydroxyphenylglycine was selected. In this manner, from 2740 colonies, Bacillus sp. KNK245 (FERM BP-4863) was isolated.

Bacillus sp. Determination of N-terminal amino acid sequence of hydantoinase derived from KNK245 Bacillus sp. One platinum loop of KNK245 strain was inoculated into 100 ml of seed medium (meat extract 1.0%, peptone 1.0%, yeast extract 0.5%; pH 7.5) in a 500 ml Sakaguchi flask, and at 55 ° C. for 19 hours. Cultured. Then, 2% of this was added to the main culture medium (meat extract 1.0%, peptone 1.0%, yeast extract 0.5%, uracil 0.1%, manganese chloride tetrahydrate 20 ppm; pH 7 5) Inoculated into 500 ml and cultured at 55 ° C. for 19 hours. Bacterial cells were collected from the obtained 9 liter culture broth by centrifugation. This was suspended in 0.2 M Tris-HCl (pH 8.0) 20 mM manganese sulfate, ultrasonically pulverized, and then centrifuged. A cell-free extract was obtained. Next, it refine | purified to 32 times using the fraction by ammonium sulfate precipitation, DEAE-Sepharose, and phenyl-Sepharose. Furthermore, hydantoinase crystals were obtained using ammonium sulfate. This crystal was dissolved in water and analyzed with a 470A gas phase protein sequencer (Applied Biosystems). Hydantoinase was found at the N-terminus,
Met-Lys-Lys-Ile-Ile-Lys-Asn-Gly-Thr-Ile-Val-Thr-
It was found to have the amino acid sequence

Agrobacterium sp. Obtaining a plasmid containing a gene related to hydantoinase derived from KNK712 (FERM BP-1900) The hydantoinase gene is present on the DNA fragment cloned in the plasmid pAHD101 described in WO92 / 10579 as follows. It was found by examining the method. pAHD101 was transformed into Escherichia coli JM109 by a conventional method and inoculated into 50 ml of L-broth (peptone 10 g / liter, yeast extract 5 g / liter, sodium chloride 5 g / liter; pH 7.0) containing 100 mg / liter ampicillin. And cultured at 37 ° C. for 16 hours. Next, 50 ml of the culture solution was collected, the supernatant was removed, and 50 ml of the substrate solution (0.5% 5- (parahydroxyphenyl) hydantoin, 0.05% Triton X-100, 0.05 M phosphate buffer solution) The cells were suspended in pH 8.7) and reacted at 37 ° C. for 3 hours under a nitrogen stream. This reaction solution was spotted on TLC, developed, and developed with a hydrochloric acid solution of p-dimethylaminobenzaldehyde. As a result, a DN-carbamoyl- (parahydroxyphenyl) glycine spot consistent with the standard product was shown. From the above, it was confirmed that the transformant of pAHD101 expressed a gene encoding hydantoinase.
The 2.1 pbp fragment obtained by digesting plasmid pAHD101 with SacI and SalI and shortening the inserted fragment was ligated with the SacI, SalI digested fragment of pUC18 to obtain plasmid pAH1043 (see FIG. 1).
In addition, the base sequence of the hydantoinase gene was determined using a DNA sequence kit (Applied Biosystems). The results are shown in SEQ ID NO: 1 in the sequence listing.
Escherichia coli HB101 was transformed with the plasmid pAH1043 to obtain a transformant Escherichia coli HB101 pAH1043 (FERM BP-4865).

Bacillus sp. Creation of recombinant DNA of KNK245 chromosomal DNA and vector DNA Bacillus sp. In 2 liters of liquid medium (meat extract 10 g / liter, peptone 10 g / liter, yeast extract 5 g / liter; pH 7.5). KNK245 (FERM BP-4863) was cultured at 45 ° C. for 24 hours and then collected to obtain bacterial cells. Chromosomal DNA was extracted from the obtained bacterial cells according to the Marmur method. To 1 μg of this chromosomal DNA, 10 U of BamHI was added and reacted at 37 ° C. for 16 hours for complete degradation.
Separately, plasmid pUC19 was completely cleaved with BamHI and ligated with the previously obtained DNA fragment from the chromosome by T4 DNA ligase to obtain a mixture of various recombinant plasmids.

Bacillus sp. Acquisition of hydantoinase gene derived from KNK245 Agrobacterium sp. Based on the base sequence of hydantoinase gene derived from KNK712 (FERM BP-1900) and Lu1220 strain shown in JP-A-62-87089, the base sequence of 1155 bp in length of these sequences is sandwiched between each complementary strand. Two types of reverse primers 1 and 2 (Table 2) having sequences were synthesized. Bacillus sp. Prepared in Example 4 When polymerase chain reaction (PCR) was performed using two types of primers synthesized using chromosomal DNA derived from KNK245 as a template, a fragment of about 1.2 kbp could be obtained. When the base sequence of this fragment was determined using a DNA sequence kit (Applied Biosystems), it was highly homologous to the base sequence of a known hydantoinase gene, and the resulting PCR fragment was one of the hydantoinase genes. It turned out to be a part. Next, two types of reverse primers 3 and 4 (Table 2) having the sequence of each complementary strand of this fragment were synthesized.
Furthermore, the primer 5 (Table 2) having the sequence of the vector portion of the recombinant DNA of Example 4 was synthesized, and the recombinant DNA of Example 1 was synthesized using the previously synthesized primer and this primer. PCR was performed on the template to obtain two types of DNA fragments including the first half and the second half of the hydantoinase gene. And the base sequence of these DNA fragments was determined. The translation initiation codon is determined from the nucleotide sequence predicted from the N-terminal amino acid sequence of the hydantoinase protein shown in Example 2, and the entire nucleotide sequence of the gene encoding hydantoinase is determined together with the result of the previously determined nucleotide sequence. did.
Next, based on the base sequence thus obtained, primer 6 (Table 2) having a restriction enzyme NdeI cleavage sequence in the vicinity of the start codon of the hydantoinase gene and the PstI cleavage site in the hydantoinase gene. Primer 7 having a sequence (Table 2) was synthesized, and PCR was carried out using the chromosomal DNA of Example 1 as a template using these primers to obtain 1.2 kb fragment 1. Next, primer 8 (Table 2) reverse in the previous PstI cleavage site and primer 9 (Table 2) having the sequence after the stop codon and having the sequence of HindIII cleavage site were synthesized. PCR was performed using the chromosomal DNA of 1 as a template to obtain a fragment 2 of 0.25 kb. Fragment 1 was ligated with NdeI and PstI, fragment 2 was ligated with PstI and HindIII, and the pUC19 improved vector plasmid pUCNT shown in WO94 / 03613 was ligated with NdeI and HindIII, and the hydantoinase gene was ligated with T4 DNA ligase. Plasmid pTH102 containing was obtained (see FIG. 2).

Bacillus sp. Creation of recombinant DNA for expression of KNK245 hydantoinase gene PCR was performed in the same manner as that for obtaining fragment 2 of Example 5 to obtain 0.25 kb fragment 3. However, the synthetic primer used at this time was a primer 10 in which the NdeI cleavage site near the PstI cleavage site was substituted by 1 base instead of the primer having the PstI cleavage site used when obtaining fragment 2, and thus could not be cleaved with NdeI. Instead of the primer in the vicinity of the stop codon (Table 2), the primer 11 (Table 2) in which the number of bases after the stop codon was further reduced was used. Next, plasmid pTH103 was obtained from fragments 1 and 3 and pUCNT in the same manner as that for obtaining pTH102 of Example 5 (see FIG. 3).
Furthermore, pTH104 was obtained in the same manner as that for obtaining pTH103, except that primer 12 (Table 2) in which the stop codon TAG of primer 11 near the stop codon was mutated to TAA was used (see FIG. 4). .
Escherichia coli HB101 transformed with pTH104 was designated as Escherichia coli HB101 pTH104. This strain has been deposited at the Biotechnology Institute of Technology from November 2, 1994 under the deposit number of FERM BP-4864.

Pseudomonas sp. Obtaining a plasmid containing a gene related to hydantoinase derived from KNK003A (FERM BP-3181) By the same method as in Example 3, it was found that the hydantoinase gene was present in the plasmid pPHD301 described in WO92 / 10579.
Escherichia coli HB101 was transformed with pPHD301 to obtain Escherichia coli HB101pPHD301 (FERM BP-4866). FIG. 5 shows a restriction enzyme map of pPHD301.
Moreover, the base sequence of the hydantoinase gene was determined in the same manner as in Example 3, and the result is shown in SEQ ID NO: 3 in the sequence listing.

Conversion of 5- (parahydroxyphenyl) hydantoin to DN-carbamoyl- (parahydroxyphenyl) glycine by the enzyme obtained from the transformed strain Escherichia coli HB101pTH104 of the transformed strain obtained in Example 6 Inoculated in 50 ml of 2YT broth (polypeptone 16 g / liter, yeast extract 10 g / liter, sodium chloride 5 g / liter; pH 7.0) containing 100 μg / ml of ampicillin and 400 ppm of manganese chloride tetrahydrate at 37 ° C. for 24 hours. Cultured. Cells were collected from 50 ml of this culture solution and suspended in 0.05 M carbonate buffer pH 8.7 to make 50 ml. TritonX-100 was added to this to a final concentration of 0.05%, 1.5 g of 5- (parahydroxyphenyl) hydantoin was added, and the pH was controlled at pH 8.7 with 6N caustic soda under a nitrogen stream. The reaction was carried out by stirring for 3 hours while keeping the temperature at 40 ° C. Centrifugation of the reaction solution after the reaction and formation of supernatant Colorimetric determination of DN-carbamoyl- (parahydroxyphenyl) glycine was performed by color development with 10% paradimethylaminobenzaldehyde in concentrated hydrochloric acid solution. DN-carbamoyl- (parahydroxyphenyl) glycine was produced at a rate of 97.5%.
The reaction solution was adjusted to pH 5 with hydrochloric acid and centrifuged, and then the supernatant was concentrated, adjusted to pH 2 with hydrochloric acid, stored at 4 ° C., and the precipitated crystals were collected by filtration. Recrystallization from water-ethanol gave 970 mg of DN-carbamoyl- (parahydroxyphenyl) glycine. M.p. 176-177 [deg.] C, [[alpha]] D20 = -177.0 [deg.] (C = 0.5, 5% ethanol).

Preparation of immobilized hydantoinase 1 liter of a culture solution of Escherichia coli HB101pTH104 obtained in the same manner as in Example 7 was collected, suspended in 1 mM aqueous manganese sulfate solution, adjusted to 60 ml, adjusted to pH 8.5, The bacterial cells were crushed by sound waves. 20 g of the anion exchange resin Duolite A-568 equilibrated to pH 8.5 was added to the enzyme solution thus obtained, and the mixture was stirred at 15 ° C. for 20 hours to adsorb the enzyme. Glutaraldehyde was added to this solution to a final concentration of 0.1%, and the mixture was stirred for 1 hour to carry out a crosslinking treatment. Thereafter, the resin was collected by filtration and washed to obtain 20 g of immobilized hydantoinase.

Conversion of 5- (parahydroxyphenyl) hydantoin to DN-carbamoyl- (parahydroxyphenyl) glycine by immobilized enzyme 5 mM of the immobilized hydantoinase obtained in Example 9 was passed through nitrogen atmosphere at 40 ° C. in 1 mM manganese sulfate aqueous solution. After adding to 100 ml, the reaction was carried out by adding 3 g of 5- (parahydroxyphenyl) hydantoin and controlling the pH to 8.7 with 6N sodium hydroxide and stirring at 40 ° C. for 3 hours under nitrogen flow. After the reaction, the reaction solution was allowed to stand and collected by suction, and then the produced carbamoylamino acid was purified in the same manner as in Example 8 to obtain 2.2 g of DN-carbamoyl- (parahydroxyphenyl) glycine.

Bacillus sp. Expression of KNK245 hydantoinase gene in Bacillus subtilis According to the method described in Example 5, Bacillus sp. PCR was performed using the chromosomal DNA derived from KNK245 as a template and primers 12 and 13 (Table 2) to obtain a 1.7 kb fragment. This was cleaved with BamHI and HindIII, and ligated with the similarly cleaved plasmid pHY300PLK (Takara Shuzo) to obtain plasmid pTHB301. The restriction enzyme map is shown in FIG.
This plasmid pTHB301 was applied to Bacillus subtilis ISW1214 (obtained from Takara Shuzo), Bacillus subtilis YS-11 (IAM12019) or Bacillus subtilis 3115 (IAM12020) using an electroporation method (GTE-10 type manufactured by Shimadzu Corporation, 10 KV / cm, 2 ms) and cultured at 37 ° C. for 20 hours in a medium obtained by adding 0.02 g / liter of MnCl2 · 4H2O to the medium shown in Example 4. A cell-free extract was prepared by collecting bacterial cells and crushing them with ultrasonic waves. As a result, Bacillus sp. The specific activity of hydantoinase was about 2.2 times higher than that when KNK245 was cultured under the same conditions.

Bacillus sp. Expression of KNK245 hydantoinase gene in thermophile Plasmid pTHB301 prepared in Example 11 was transformed into Bacillus stearothermophilus IFO12550 by protoplast method (according to J. Bacteriol., 149, 824 (1982)). The cells were transformed and cultured in the same manner as in Example 11 to prepare a cell-free extract. Bacillus sp. Compared with the cell-free extract of KNK245, the specific activity of hydantoinase was about 3.6 times higher.
As described above, according to the present invention, microorganisms with extremely high hydantoinase productivity can be created, and by using this as an enzyme source, DN-carbamoyl-α-amino acid can be produced efficiently.

It is a restriction map of plasmid pAH1043. It is a restriction map of plasmid pTH102. It is a restriction enzyme map of plasmid pTH103. It is a restriction enzyme map of plasmid pTH104. It is a restriction enzyme map of plasmid pPHD301. It is a restriction map of plasmid pTHB301. The sequence listing is shown. Continuation of the sequence listing. Continuation of the sequence listing. Continuation of the sequence listing. Continuation of the sequence listing. Continuation of the sequence listing. Continuation of the sequence listing. Continuation of the sequence listing. Continuation of the sequence listing. Continuation of the sequence listing. Continuation of the sequence listing. Continuation of the sequence listing. Continuation of the sequence listing. Continuation of the sequence listing. Continuation of the sequence listing. Continuation of the sequence listing. Continuation of the sequence listing.

Claims (19)

Bacillus sp. Using KNK245 (FERM BP-4863) chromosomal DNA as a template, PCR was performed using the primer set of primer 6 and primer 7 shown below, and the resulting fragment was cleaved with NdeI and PstI,
Bacillus sp. KNK245 (FERM BP-4863) chromosomal DNA as a template, selected from the group consisting of the primer set of primer 8 and primer 9, the primer set of primer 10 and primer 11, and the primer set of primer 10 and primer 12 shown below PCR was performed using a primer set, and the obtained DNA fragment was digested with PstI and HindIII,
Obtained by ligating the vector plasmid pUCNT with NdeI and HindIII with T4 DNA ligase,
NdeI immediately after the lac promoter of a recombinant DNA containing a gene encoding an enzyme (hereinafter referred to as hydantoinase) that asymmetrically cleaves and hydrolyzes a 5-substituted hydantoin into the corresponding DN-carbamoyl-α-amino acid. A DNA fragment containing a gene encoding hydantoinase contained from the site to the HindIII site;
A transformed microorganism obtained by transforming a host microorganism using a recombinant DNA with a vector DNA.

The vector DNA is pUCNT and the recombinant plasmid is

The transformed microorganism according to claim 1, which is a recombinant plasmid represented by the restriction enzyme map shown in any one of the above. The transformation according to claim 1 or 2, wherein the host microorganism is selected from microorganisms belonging to the genus Escherichia, Pseudomonas, Flavobacterium, Bacillus, Serratia, Agrobacterium, Corynebacterium or Brevibacterium. Microorganisms. The transformed microorganism according to claim 3, wherein the transformed microorganism is Escherichia coli HB101 pTH104 (FERM BP-4864). The transformed microorganism according to any one of claims 1 to 4, or Pseudomonas sp. The 5-substituted hydantoin derived from KNK003A (FERM BP-3181) and having the amino acid sequence of SEQ ID NO: 3 is asymmetrically cleaved and hydrolyzed to give the corresponding DN-carbamoyl-α. -Using a transformed microorganism obtained by transforming a host microorganism using a recombinant DNA of a DNA fragment containing a gene encoding an enzyme that converts to an amino acid (hereinafter referred to as hydantoinase) and a vector DNA. A method for producing an enzyme, wherein the characteristic 5-substituted hydantoin is asymmetrically hydrolyzed to the corresponding DN-carbamoyl-α-amino acid. 6. The process according to claim 5, wherein the host microorganism is selected from microorganisms belonging to the genus Escherichia, Pseudomonas, Flavobacterium, Bacillus, Serratia, Agrobacterium, Corynebacterium or Brevibacterium. The transformed microorganism is Escherichia coli HB101 pTH104 (FERM BP-4864), Escherichia coli HB101 pAH1043 (FERM BP-4865) or Escherichia coli HB101 pPHDB (FER BP48P) The method according to claim 6, wherein A method for producing DN-carbamoyl-α-amino acid from 5-substituted hydantoin, which comprises using the enzyme obtained by the production method according to claim 5. 5-substituted hydantoins are represented by the general formula (1):

9. The process according to claim 8, wherein R is a compound represented by the formula: R represents a phenyl group, a phenyl group substituted with a hydroxyl group, an alkyl group, a substituted alkyl group, an aralkyl group or a thienyl group. Bacillus sp. Using KNK245 (FERM BP-4863) chromosomal DNA as a template, PCR was performed using the primer set of primer 6 and primer 7 shown below, and the resulting fragment was cleaved with NdeI and PstI,
Bacillus sp. KNK245 (FERM BP-4863) chromosomal DNA as a template, selected from the group consisting of the primer set of primer 8 and primer 9, the primer set of primer 10 and primer 11, and the primer set of primer 10 and primer 12 shown below PCR was performed using a primer set, and the obtained DNA fragment was digested with PstI and HindIII,
An enzyme obtained by ligating a vector plasmid pUCNT with NdeI and HindIII and ligating it with T4 DNA ligase to asymmetrically cleave and hydrolyze a 5-substituted hydantoin into the corresponding DN-carbamoyl-α-amino acid A DNA fragment containing a gene encoding hydantoinase, which is contained from the NdeI site immediately after the lac promoter to the HindIII site of a recombinant DNA containing a gene encoding (hereinafter referred to as hydantoinase);
Recombinant plasmid with vector plasmid.

The vector plasmid is pUCNT,

The recombinant plasmid of Claim 10 shown by the restriction enzyme map shown in either. The plasmid pAHD101 was digested with SacI and SalI, and the obtained 2.1 kbp fragment was ligated with the SacI and SalI digested fragment of pUC18.

Recombinant plasmid shown in the restriction enzyme map. Escherichia coli HB101 pAH1043 (FERM BP-4865). The plasmid according to claim 10, wherein

Of the recombinant plasmid shown in the restriction enzyme map of ## STR1 ## which is contained from the NdeI site to the HindIII site immediately after the lac promoter, and the corresponding DN-carbamoyl-α is obtained by asymmetric cleavage hydrolysis of the 5-substituted hydantoin. -A gene of a protein exhibiting an enzymatic activity to be converted into an amino acid. The plasmid according to claim 11, wherein

A protein having an enzyme activity obtained by expressing a recombinant plasmid represented by the restriction enzyme map of (a) and converting the 5-substituted hydantoin into a corresponding DN-carbamoyl-α-amino acid by asymmetric cleavage hydrolysis. A DNA fragment containing the encoding gene. The plasmid according to claim 11, wherein

Of the recombinant plasmid shown in the restriction enzyme map of Fig. 5 having an amino acid sequence contained in the amino acid sequence encoded by the gene from the NdeI site to the HindIII site immediately after the lac promoter, and asymmetrically cleaving and hydrolyzing 5-substituted hydantoins An enzyme protein having an activity of converting to the corresponding DN-carbamoyl-α-amino acid. A gene of a protein having an amino acid sequence of SEQ ID NO: 3 and having an enzyme activity that asymmetrically cleaves and hydrolyzes a 5-substituted hydantoin to convert it to the corresponding DN-carbamoyl-α-amino acid. It has a base sequence of base numbers 60 to 1517 of SEQ ID NO: 3 and has an enzyme activity to asymmetrically cleave and hydrolyze a 5-substituted hydantoin and convert it to the corresponding DN-carbamoyl-α-amino acid. A DNA fragment containing the gene of the indicated protein. An enzyme protein comprising the amino acid sequence of SEQ ID NO: 3 and having an activity of asymmetrically hydrolyzing a 5-substituted hydantoin to convert it to the corresponding DN-carbamoyl-α-amino acid.

Images